RS1731243 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (16)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Mean arterial pressure x alcohol consumption interaction (2df test) | T | — | 8E-30 | PubMed |
| Medication use (agents acting on the renin-angiotensin system) | C | β: 0.065 | 8E-26 | PubMed |
| Diastolic blood pressure x alcohol consumption interaction (2df test) | T | — | 1E-23 | PubMed |
| Hypertension | T | OR: 0.12 | 2E-18 | PubMed |
| Body mass index (BMI, maximum, inv-normal transformed) | C | β: 0.022 | 3E-14 | PubMed |
| Medication use (antihypertensives) | T | OR: 0.1 | 3E-13 | PubMed |
| Body mass index (BMI, mean, inv-normal transformed) | C | β: 0.021 | 9E-13 | PubMed |
| Body mass index (BMI, maximum, inv-normal transformed) | C | β: 0.024 | 2E-12 | PubMed |
| Body mass index (BMI, mean, inv-normal transformed) | C | β: 0.023 | 2E-11 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | C | — | 2E-10 | PubMed |
| LDL cholesterol levels | C | β: 0.013 | 7E-10 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | C | — | 2E-9 | PubMed |
| Polyunsaturated fatty acids to total fatty acids percentage | C | — | 2E-9 | PubMed |
| Weight | T | β: 0.019 | 4E-9 | PubMed |
| Monounsaturated fatty acid levels | C | — | 4E-9 | PubMed |
| Treatment effectiveness of calcium channel blocker-dihydropyridine in hypertension | T | OR: 0.9 | 7E-6 | PubMed |